Vascular progenitor cells in diabetes mellitus: roles of Wnt signaling and negatively charged low-density lipoprotein.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease.International journal of molecular medicine · 2016
   Article
2. Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.Diabetes · 2013
   Article
3. Endothelial progenitor cells in atherosclerosis.Frontiers in bioscience (Landmark edition) · 2012
   Review
4. Hypoxia promotes growth of stem cells in dental follicle cell populations.Journal of biomedical science and engineering · 2011
   Article

Corrections and comments

• Comment on
  Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.2009

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as